Study on the effects of hydroxyapatite (HA) and artificial bone prosthesis made of beta-TCP in implant treatment (randomized controlled trial)

Study on the effects of hydroxyapatite (HA) and artificial bone prosthesis made of beta-TCP in implant treatment (randomized controlled trial) - Study on the effects of artificial bone prosthesis (HA and beta-TCP) in implant treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027392

Enrollment

Registered

2017-05-31

Start date

2017-05-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with bone defect

Interventions

Duration:1 year Bone formation using cerasorb or Arrowbone beta dental at the same time as the dental implant placement or 2nd term is performed and bone level is confirmed by dental radiograph 1 yea

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with albeolar bone defect

Exclusion criteria

Exclusion criteria: patient with poor general condition

Design outcomes

Primary

Measure	Time frame
survival rate after one year of the dental implant placed in the augmented bone	—

Countries

Japan

Contacts

Public ContactFumio Suehiro

Graduate School of Medical and Dental Sciences, Kagoshima University Department of Oral and Maxillofacial Prosthodontics

fsuehiro@dent.kagoshima-u.ac.jp099-275-6222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026